Literature DB >> 26142621

The costs of accessing abortion in South Africa: women's costs associated with second-trimester abortion services in Western Cape Province.

Naomi Lince-Deroche1, Deborah Constant2, Jane Harries2, Kelly Blanchard3, Edina Sinanovic4, Daniel Grossman5.   

Abstract

OBJECTIVES: To assess women's costs of accessing second-trimester labor induction and dilation and evacuation (D&E) services at four public hospitals in Western Cape Province, South Africa. STUDY
DESIGN: From April to August 2010, in interviews immediately after completion of their abortion, we asked women about specific direct and indirect costs incurred. We collected information on recurring costs (i.e., per visit) and one-time expenditures and calculated total costs.
RESULTS: In total, 194 patients participated (136 D&E; 58 induction). Their median age was 26; 37.6% reported being employed or doing paid work. Most (73.2%) women visited two different facilities, including the study facility, while seeking the procedure. Induction women reported a median of three required visits [interquartile range (IQR) 2.0-3.0] to the study facility, while D&E women reported two required visits [IQR 1.0-2.0]. Twenty-seven percent of women missed work due to the procedure, and few (4.6%) paid for childcare. At each visit, almost all women (180, 92.8%) paid for transportation costs and reported additional one-time costs (177, 91.2%) such as sanitary supplies or doctor's fees. The total median cost incurred per woman was $21.23 [IQR 11.94-44.68]. Roughly half (49.0%) received help with these costs.
CONCLUSIONS: Although technically offered freely or low cost in the public sector, women accessing second-trimester abortion lost income and incurred costs for transport, fees, supplies and childcare. Their total costs could be reduced by minimizing the number of required visits to facilities and freely offering supplies such as sanitary pads and pregnancy tests. IMPLICATIONS: Limited access to second-trimester, safe abortion services in South Africa may result in some women incurring unnecessary costs. Women make multiple visits in attempting to obtain an abortion, often because of facility or health systems requirements, and incur costs for lost income, child care, transport, fees and supplies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dilation and evacuation; Economic; Labor induction; Termination of pregnancy

Mesh:

Year:  2015        PMID: 26142621     DOI: 10.1016/j.contraception.2015.06.029

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Women's reproductive decision making and abortion experiences in Cape Town, South Africa: A qualitative study.

Authors:  Marie E Sullivan; Abigail Harrison; Jane Harries; Namhla Sicwebu; Rochelle K Rosen; Omar Galárraga
Journal:  Health Care Women Int       Date:  2017-12-15

2.  Women's embodied experiences of second trimester medical abortion.

Authors:  Carrie Purcell; Audrey Brown; Catriona Melville; Lisa M McDaid
Journal:  Fem Psychol       Date:  2017-01-01

3.  The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.

Authors:  Naomi Lince-Deroche; Deborah Constant; Jane Harries; Judith Kluge; Kelly Blanchard; Edina Sinanovic; Daniel Grossman
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

4.  Women's costs for accessing comprehensive sexual and reproductive health services: findings from an observational study in Johannesburg, South Africa.

Authors:  Naomi Lince-Deroche; Kaitlyn M Berry; Cheryl Hendrickson; Tembeka Sineke; Sharon Kgowedi; Masangu Mulongo
Journal:  Reprod Health       Date:  2019-12-16       Impact factor: 3.223

Review 5.  The mesoeconomics of abortion: A scoping review and analysis of the economic effects of abortion on health systems.

Authors:  Samantha R Lattof; Ernestina Coast; Yana van der Meulen Rodgers; Brittany Moore; Cheri Poss
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.